Prevalence of antibiotic resistance in Helicobacter pylori strains in Poland

Clinical Microbiology and Infection

Volumn 4, Issue 12, 1998, Pages 726-728

  Gosciniak, G ^a   Glupczynski, Y ^b   Gautier, S ^b   Van Den Borre, C ^b   Bntzler, J P ^b   Przondo Mordarska, A ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POLAND; PREVALENCE; PRIORITY JOURNAL;

HELICOBACTER PYLORI;

EID: 0032420587     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00659.x     Document Type: Review

References (5)

1. Sipponen P, Hyvarinen H. Role of H. pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1992; 28(suppl 196): 3-6.
2. Rożynek E, Dzierżanowska D, Celińska-Cedro D, Kepa Z, Socha J. The susceptibility of the strains of H. pylori isolated from children to metronidazole and 5 antibiotics. Gastroenterol Pol 1995; 2: 129-33.
3. De Korwin JD, Lozniewski A. Treatment of H. pylori infection. Presse Med 1996; 25: 1917-22.
4. Andrzejewska E, Klincewicz H. In vitro susceptibility of H. pylori strains to several antimicrobial agents. Gastroenterol Pol 1995; 2: 309-12.
5. Vasquez A, Valdez Y, Gilman RH, et al. Metronidazole and clarithromycin resistance in H. pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. J Clin Microbiol 1996; 34: 1232-4.